R21/Matrix-M: WHO Paves Way for Oxford-Serum Malaria Vaccine’s Global Use
Pune: The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant technology, ...
Pune: The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant technology, ...